Cash Flow

v3.10.0.1
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Operating activities    
Net loss $ (26,992) $ (29,122)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 1,515 1,748
Inventory allowance expense 191 73
Provision (recovery) for doubtful accounts (50) 105
Loss on disposal of property and equipment 126 0
Amortization of debt discount and accretion of final payment fee 152 179
Gain on change in fair value of contingent liabilities (35) (213)
Common stock contribution to 401(k) plan 212 509
Stock-based compensation expense 2,868 2,414
Change in fair value of warrant liability (1,063) (3,909)
Loss on repurchase of warrants 0 1,067
Unrealized loss (gain) on foreign currency transactions 381 (500)
Changes in operating assets and liabilities    
Accounts receivable (850) (1,085)
Inventories (1,655) (2,096)
Prepaid expense and other assets, current and noncurrent 1,046 (862)
Accounts payable 752 77
Accrued liabilities 559 105
Deferred revenues 678 284
Net cash used in operating activities (22,165) (31,226)
Investing activities    
Acquisition of property and equipment, net (131) (456)
Net cash used in investing activities (131) (456)
Financing activities    
Principal payments on notes payable (2,174) (54)
Proceeds from issuance of common stock, net 4,446 42,463
Proceeds from exercise of stock options 1 46
Proceeds from exercise of common stock warrants 0 113
Net cash provided by financing activities 2,273 42,568
Effect of exchange rate changes on cash (135) 81
Net (decrease) increase in cash (20,158) 10,967
Cash at beginning of the period 27,813 16,846
Cash at end of the period 7,655 27,813
Supplemental disclosure of cash flow activities    
Cash paid for interest 457 429
Cash paid for income taxes 18 20
Supplemental disclosure of non-cash activities    
Transfer of inventory to equipment 1,118 554
Share issuance for common stock contribution to 401(k) plan 508 0
Share issuance for in lieu of cash compensation 291 0
Share issuance for vesting of restricted stock 1 0
Equipois sales earn-out 28 47
Equipois supply earn-out 0 189
April 2017 warrant issuance 0 3,301
Repurchase of April 2017 warrants and share issuance 0 2,245
Cumulative retrospective adjustment to retained earnings for ASU 2016-09 adoption 0 171
Reclassification of warrant liability to equity upon exercise of warrants $ 0 $ 62

Source